Blanket Purchase Agreement GS35F0398V-75F40121A00006

Award Date 4/22/21
Last Date to Order 4/25/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Clinger Cohen Act
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Blanket Purchase Agreement was awarded by the Department of Health and Human Services Food and Drug Administration to Ignyte Group Inc. as a single-award contract under the Multiple Award Schedule. With a potential value of $140 million and a period of performance through April 2026, the BPA aims to procure CDER Workflow Management Program services. The CDER WFM BPA will provide services to support the Center for Drug Evaluation and Research's workflow management initiatives. This includes...
The Blanket Purchase Agreement (BPA) was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Technology Solutions Provider, Inc. as a single-award contract under the Multiple Award Schedule. With a potential value of $140 million, the BPA aims to procure workflow management services for the FDA's Center for Drug Evaluation and Research over a five-year period of performance ending in April 2026. The BPA will facilitate task orders related to the CDER...
This Blanket Purchase Agreement (BPA) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Accenture Federal Services LLC, a global professional services company. The BPA, valued at up to $90 million, is for the provision of scientific, program management, and informatics governance modernization support services to the FDA's Center for Drug Evaluation and Research (CDER). Specific task orders issued under the BPA include a $13.4 million firm fixed-price...
The Department of Health and Human Services Food and Drug Administration awarded a single award Blanket Purchase Agreement to Rei Systems, Inc. under the Multiple Award Schedule contracting vehicle. With a potential value of $140 million and a period of performance through April 2026, this BPA aims to procure CDER Workflow Management Program services. The BPA will facilitate delivery of products and services to support the Center for Drug Evaluation and Research's workflow management...
The Department of Health and Human Services Food and Drug Administration awarded Deloitte Consulting LLP a $140 million Blanket Purchase Agreement to provide various services supporting the agency's workflow management programs. Under the agreement's initial task order, Deloitte will establish and operate a Workflow Management Center of Excellence in Calverton, Maryland from May 2021 through May 2024 valued at $25.2 million. Additional firm fixed price and labor hour task orders were awarded for...
The Department of Health and Human Services Food and Drug Administration awarded a single award Blanket Purchase Agreement to Contact Government Services LLC valued at up to $60,000,000 to provide eDiscovery operational support services and technology management. Under the terms of the BPA, the FDA issued an initial task order worth $5,779,831.34 for eDiscovery services with a period of performance from September 2023 through March 2026 in Washington D.C. The BPA and first task order aim to...
The Blanket Purchase Agreement (BPA) awarded to Accenture Federal Services LLC by the Food and Drug Administration (FDA) is a single-award contract valued at up to $332,000,000 over its 6-year period of performance from October 2020 to September 2026. The contract was awarded under the General Services Administration's (GSA) Multiple Award Schedule (MAS) federal acquisition vehicle and is designated as a non-set-aside. The purpose of this BPA is to provide the FDA's Business Transformation...
This Blanket Purchase Agreement (BPA) contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to the prime contractor Booz Allen Hamilton Inc., a prominent management and technology consulting firm. The contract has a ceiling value of $100,000,000 and a period of performance through July 31, 2027. The contract vehicle is the General Services Administration's (GSA) Multiple Award Schedule (MAS). The BPA contract is for Next Generation Regulatory Business Information...
This Blanket Purchase Agreement (BPA) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to the prime contractor LMI Consulting, LLC, a for-profit limited liability company that provides management consulting services to government clients. The BPA, issued against the General Services Administration's (GSA) Multiple Award Schedule (MAS) contract vehicle, has a total ceiling value of $149,000,000 and an ultimate completion date of March 26, 2028. The BPA covers a...
The Blanket Purchase Agreement (BPA) awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Accenture Federal Services LLC provides a range of business transformation and process improvement services. The $332 million, single-award contract, which runs through March 2026, leverages the General Services Administration's Multiple Award Schedule (MAS) contract vehicle to efficiently deliver professional services in areas such as digital transformation, data analytics,...

The Blanket Purchase Agreement was awarded by the Department of Health and Human Services Food and Drug Administration to Collabralink Technologies, Incorporated for CDER WORKFLOW MANAGEMENT PROGRAM (WFM) services. The single award contract has a potential value of $140 million and a period of performance through April 2026.

The BPA aims to procure workflow management services to support the Center for Drug Evaluation and Research. Specifically, the prime contractor will deliver solutions for electronic submissions processing, review management, labeling and packaging, and regulatory business processes. These services will enhance the agency's ability to evaluate new drugs and ensure safe, effective pharmaceutical products are available to the public. Relevant task orders and price lists will facilitate delivery of software hosting, application maintenance, and professional services over the life of the contract.

The award was made without a set-aside through the General Services Administration Multiple Award Schedule contracting vehicle. Performance will take place at locations to be determined in support of the FDA's drug evaluation program. The single award structure and large potential value indicate a need for an integrated suite of solutions and management over several years to modernize the agency's drug review workflow and related regulatory information technology systems.

Generated 1/4/24, 6:37 PM